Show simple item record

dc.contributor.authorKhan, AA
dc.contributor.authorHernan, I
dc.contributor.authorAdamthwaite, JA
dc.contributor.authorRamsey, KWD
dc.date.accessioned2018-10-09T11:50:43Z
dc.date.issued2019-01
dc.identifier.citationThe British journal of surgery, 2019, 106 (1), pp. 100 - 110
dc.identifier.issn0007-1323
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/2888
dc.identifier.eissn1365-2168
dc.identifier.doi10.1002/bjs.10983
dc.description.abstractBackground Breast cancer-related lymphoedema (BCRL) presents a significant healthcare burden and adversely affects quality of life of breast cancer survivors. A prospective feasibility study was performed on lymphaticovenous anastomosis (LVA) for the treatment of BCRL.Methods Patients with BCRL underwent near-infrared spectroscopy with indocyanine green lymphatic mapping to identify suitable lymphatic channels for LVA. End-to-end anastomoses to subdermal venules were performed and patients recommenced compression garment therapy (CGT) after surgery. Volumetric assessment of the affected limb was performed at regular intervals using infrared perometry to calculate the excess volume reduction.Results Over a 24-month interval, 27 patients with BCRL underwent LVA. The mean duration of lymphoedema was 3·5 (range 0·5-18) years, and the mean number of LVAs performed was 3 (range 2-5). Twenty-four of the 27 patients completed 12-month follow-up. Patients exhibited three patterns of volumetric response following LVA: sustained response (16 patients), transient response (5) or no response (6). Sustained responders showed an excess volume reduction of -33·2 per cent at 12 months, and this correlated positively with the number of LVAs performed (r = -0·56, P = 0·034). Overall, ten patients were able to downgrade CGT after surgery, and two patients were CGT-free at 12 months.Conclusion LVA resulted in a sustained volume reduction in selected patients and may offset the burden of CGT. Further work is required to identify biomarkers that predict a favourable response to LVA surgery.
dc.formatPrint-Electronic
dc.format.extent100 - 110
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectVeins
dc.subjectLymphatic Vessels
dc.subjectHumans
dc.subjectBreast Neoplasms
dc.subjectIndocyanine Green
dc.subjectAnti-Bacterial Agents
dc.subjectAnastomosis, Surgical
dc.subjectSpectrophotometry, Infrared
dc.subjectAdministration, Oral
dc.subjectInfusions, Intravenous
dc.subjectProspective Studies
dc.subjectFeasibility Studies
dc.subjectEquipment Design
dc.subjectColoring Agents
dc.subjectFemale
dc.subjectRandomized Controlled Trials as Topic
dc.subjectBreast Cancer Lymphedema
dc.titleFeasibility study of combined dynamic imaging and lymphaticovenous anastomosis surgery for breast cancer-related lymphoedema.
dc.typeJournal Article
dcterms.dateAccepted2018-07-22
rioxxterms.versionofrecord10.1002/bjs.10983
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2019-01
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfThe British journal of surgery
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.publication-statusPublished
pubs.volume106
pubs.embargo.termsNot known
icr.researchteamTargeted Therapyen_US
dc.contributor.icrauthorKhan, Aadilen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0